Chemoinformaics analysis of 2,6-Dimethylhept-3-ene
| Molecular Weight | 126.243 | nRot | 3 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 1 |
| Exact Molecular Weight | 126.141 | nRing | 0 |
| Solubility: LogS | -4.387 | nHRing | 0 |
| Solubility: LogP | 4.366 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0323 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.509 |
| Synth | 2.69 |
| Natural Product Likeliness | 2.114 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.008 |
| HIA | 0.006 |
| CACO-2 | -4.159 |
| MDCK | 0.0000255 |
| BBB | 0.798 |
| PPB | 0.952185 |
| VDSS | 2.366 |
| FU | 0.0512534 |
| CYP1A2-inh | 0.814 |
| CYP1A2-sub | 0.527 |
| CYP2c19-inh | 0.222 |
| CYP2c19-sub | 0.912 |
| CYP2c9-inh | 0.543 |
| CYP2c9-sub | 0.944 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.269 |
| CL | 11.008 |
| T12 | 0.413 |
| hERG | 0.003 |
| Ames | 0.006 |
| ROA | 0.062 |
| SkinSen | 0.104 |
| Carcinogencity | 0.091 |
| EI | 0.993 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.943793 |